InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by CHANG JOSEPH Y, Directeur Scientifique. Director active across 1 company, notably NU Skin Enterprises, INC.. Cumulatively, 10 filings have been logged. History available since 13 September 2021. The latest transaction was filed on 1 March 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
68,485 shares@ US$30.6351.6% of flowClass A Common StockSEC:0001062993-23-005953:0
1,981 shares@ US$45.382.2% of flowClass A Common StockSEC:0001062993-23-003827:0
6,800 shares@ US$37.586.2% of flowClass A Common StockSEC:0001062993-22-024235:0
16,000 shares@ US$30.630.15% mcap30.0% of flowClass A Common StockSEC:0001062993-22-014216:0
3,423 shares@ US$30.630.032% mcap6.1% of flowClass A Common StockSEC:0001062993-22-006655:0
6,744 shares0Class A Common StockSEC:0001062993-22-006173:0
1,729 shares@ US$49.650.026% mcap4.9% of flowClass A Common StockSEC:0001062993-22-004842:0
1,729 shares@ US$49.652.0% of flowClass A Common StockSEC:0001062993-22-004842
16,000 shares@ US$30.630.14% mcap27.0% of flowClass A Common StockSEC:0001062993-21-008532:0
16,000 shares@ US$30.6310.8% of flowClass A Common StockSEC:0001062993-21-008532
10 of 10 declarations
About CHANG JOSEPH Y
Joseph Y. Chang is the Chief Scientific Officer at Nu Skin Enterprises, Inc. He is responsible for scientific strategy and innovation, playing a key role in product and technology development.
